Biofactories: producció de proteïnes recombinants en plantes

Authors

  • Maria Dolors Ludevid Mújica
  • Margarida Torrent Quetglàs

Abstract

Plants were the main source for human drugs until the beginning of the nineteenth century when plant-made pharmaceuticals were partly supplanted by drugs produced by the industrial methods of chemical synthesis. During the last decades of twentieth century, genetic engineering has offered an alternative to chemical synthesis using bacteria, yeast and animal cells as a factories for the production of recombinant proteins. With the recent development of plant-based recombinant protein production systems, plants offer a safe and extremely cost effective alternative to microbial and mammalian cell cultures. Here, we evaluate the advantages and disadvantages of different plant expression systems (stable nuclear, or transient transformations) and their current limitations or challenges. We also illustrate that current improvements in plant expression systems and plant hosts are making them suitable as alternative factories for the production of either simple or highly complex recombinant proteins.

Downloads

Download data is not yet available.

Published

2011-01-19